Trials / Completed
CompletedNCT03037918
Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans
Effect of Yakult Ingestion on Diet-induced Insulin Resistance in Humans. A Large-cohort, Mechanistic Follow-up Study.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Loughborough University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Participants will be randomly allocated to either Yakult ingestion or a control group. For the first 20 days, subjects will consume their normal diet (keeping a detailed food diary throughout). On days 21-28 they will switch to a high-fat/high-calorie diet. The investigators hypothesise that consuming a high-fat, high-energy diet for 7 days will alter the composition of the gut microbiota and induce metabolic endotoxaemia / systemic inflammation as well as decreasing whole body insulin sensitivity (as we have shown previously). In contrast, the investigators hypothesise that consuming Yakult for 21 days before and 7 days throughout the high-fat diet will maintain a favourable gut microbiota and prevent metabolic endotoxaemia / systemic inflammation and thus maintain insulin action / insulin sensitivity.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Yakult light | A fermented milk drink containing the probiotic Lactobacillus casei Shirota |
Timeline
- Start date
- 2017-02-03
- Primary completion
- 2018-08-31
- Completion
- 2018-08-31
- First posted
- 2017-01-31
- Last updated
- 2018-10-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03037918. Inclusion in this directory is not an endorsement.